kallyope glp-1 program Central and peripheral systems independently and additively suppress eating Kallyope Pipeline | Novel Therapies
Description
Matt Williams: Sure
Here is what works
Moreover, we performed OGTT on hGLP-1R mice
In the comparison of GLP-1 use vs non-use, 1,610 BC patients with obesity were included
The other group was prescribed a diabetes medication but did not use any GLP-1 drugs
